- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: pertuzumab trastuzumab nab-paclitaxel
Total 1213 results
-
Tianjin Medical University Cancer Institute and...Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruitingHER2+ Early or Locally Advanced Breast Cancer
-
Henan Cancer HospitalRecruitingBreast Cancer | HER2-positive Breast CancerChina
-
Henan Cancer HospitalRecruitingBreast Cancer,Her2 PositiveChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingHER2-positive Breast Cancer | Early-stage Breast Cancer | Adjuvant Treatment After Trastuzumab | RCB Classification 1-2 | NeratiniChina
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Breast Adenocarcinoma | Inflammatory Breast CarcinomaUnited States
-
University of Illinois at ChicagoNot yet recruitingBreast Cancer | HER2-positive Breast Cancer
-
European Organisation for Research and Treatment...Hoffmann-La RocheCompletedElderly Metastatic Breast Cancer PopulationBelgium, Italy, Netherlands, France, Poland, United Kingdom, Portugal, Sweden
-
Memorial Sloan Kettering Cancer CenterUniversity of Pennsylvania; Genentech, Inc.CompletedBreast CancerUnited States
-
Hoffmann-La RocheCompleted
-
Institut Català d'OncologiaFundación Sociedad Española de Oncologia Médica; Instituto de Salud Carlos III and other collaboratorsRecruitingNeoplasms | Breast Cancer | HER2-positive Breast CancerSpain
-
Dana-Farber Cancer InstituteJohns Hopkins University; Translational Breast Cancer Research ConsortiumNot yet recruitingBreast Cancer | HER2-positive Breast Cancer | Stage IV Breast Cancer | Breast Cancer Female | Breast Cancer Metastatic | Estrogen Receptor-positive Breast CancerUnited States
-
Shengjing HospitalNot yet recruiting
-
Hoffmann-La RocheGenentech, Inc.CompletedBreast CancerUnited States, Italy, United Kingdom, Australia, Austria, Belgium, Brazil, Denmark, France, Guatemala, Korea, Republic of, Portugal, Spain, Turkey, Colombia, Canada, Czechia, Japan, Poland, Romania, Russian Federation, Switzerland, ... and more
-
Fudan UniversityCompleted
-
Hoffmann-La RocheCompletedBreast NeoplasmsItaly, Netherlands, Belgium, United Kingdom, Argentina, Austria, Brazil, China, Ecuador, Estonia, Finland, France, Germany, Greece, Mexico, Peru, Poland, Portugal, Slovenia, Spain, United Arab Emirates, Canada, Hungary, Israel, Sweden, Tu... and more
-
NSABP Foundation IncWashington University School of Medicine; Breast Cancer Research FoundationActive, not recruiting
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)Completed
-
Genentech, Inc.CompletedMetastatic Breast CancerUnited States
-
Shanghai Jiao Tong University School of MedicineJiangsu HengRui Medicine Co., Ltd.Active, not recruitingBreast Cancer InvasiveChina
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Roche Pharma AGCompletedEsophageal CarcinomaNetherlands
-
Guangdong Provincial People's HospitalRecruitingNeoadjuvant Therapies for HER2+ Breast CancerChina
-
Fujian Medical University Union HospitalRecruiting
-
Hospices Civils de LyonNot yet recruiting
-
The Methodist Hospital Research InstituteNovartis; Celgene CorporationCompletedBreast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterUnited States Department of Defense; Genentech, Inc.CompletedBreast Cancer Metastases | HER2 Positive BreastUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingA Trial of Eribulin in Combination With HP Neoadjuvant Therapy in Patients With for HER2-Positive BCHER2-positive Breast CancerChina
-
Genentech, Inc.Approved for marketing
-
Hoffmann-La RocheCompletedHER2-Positive Early Breast CancerUnited States, Finland, Hong Kong, Panama, Portugal, Spain, Mexico, Sweden, Brazil, Serbia, Argentina, Lebanon, Cuba, Qatar, Saudi Arabia, Chile, Jordan
-
Hoffmann-La RocheRecruitingLocally Advanced or Metastatic Breast CancerFrance, Belgium, United States, Korea, Republic of, Taiwan, Brazil, China, Italy, Argentina, Jordan, Mexico, Germany, Portugal, Spain, Thailand, United Kingdom, Kenya, Turkey, Hungary, Colombia, India, Oman, Saudi Arabia, Poland, Uganda, United... and more
-
Fundacio Clinic BarcelonaRoche Pharma AG; SOLTI Breast Cancer Research GroupRecruitingStage I Breast Cancer | HER2-positive Breast CancerSpain
-
H. Lee Moffitt Cancer Center and Research InstituteWithdrawnBreast CancerUnited States
-
David Garcia CincaFundacion Clinic per a la Recerca BiomédicaNot yet recruiting
-
Hoffmann-La RocheCompleted
-
Zhe Jiang Hisun Bioray Bio-pharmaceu tical Co.LtdUnknown
-
Hoffmann-La RocheActive, not recruitingInflammatory Breast Cancer | Early Breast Cancer | Locally Advanced Breast CancerCanada, Croatia, Spain, Argentina, Mexico, Korea, Republic of, Bosnia and Herzegovina, Brazil, Costa Rica, Turkey, Singapore, Bulgaria, South Africa, India, Peru, Kenya, Chile
-
US Oncology ResearchGenentech, Inc.TerminatedBreast Neoplasms | Malignant Tumor of the BreastUnited States
-
Peking University Cancer Hospital & InstituteRecruitingHER2-positive Metastatic Breast Cancer | Previously Treated With Trastuzumab | Trastuzumab Combined With Pertuzumab and ChemotherapyChina
-
Jules Bordet InstituteHoffmann-La Roche; Breast International Group; Institut Curie; International Drug...SuspendedHER2-positive Breast Cancer | ER-Negative Breast Cancer | PR-Negative Breast Cancer | Node-negative Breast CancerKorea, Republic of, France, Israel, Belgium, Switzerland, Australia
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Synta Pharmaceuticals Corp.; New York University...CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
AgendiaUniversity of South Florida; University of Miami; University of Oklahoma; Ohio... and other collaboratorsCompletedBreast CancerUnited States
-
QuantumLeap Healthcare CollaborativeRecruitingBreast Cancer | Breast Neoplasms | Breast Tumors | HER2-positive Breast Cancer | Angiosarcoma | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast CancerUnited States
-
National Cancer Institute (NCI)TerminatedAnatomic Stage IV Breast Cancer AJCC v8 | Metastatic Breast Carcinoma | HER2-Positive Breast CarcinomaUnited States
-
Fudan UniversityActive, not recruitingTNBC - Triple-Negative Breast CancerChina
-
Intergroupe Francophone de Cancerologie ThoraciqueCompletedNon Small Cell Lung Cancer Metastatic | HER2 Gene Mutation | Non Small Cell Lung Cancer Stage IIIFrance
-
National Cancer Institute (NCI)Active, not recruitingMalignant Solid NeoplasmUnited States
-
Thomas HatschekActive, not recruitingEarly-Stage Breast Carcinoma | HER-2 Positive Breast CancerSweden
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingHER2-PositiveRecurrent or Metastatic Breast Cancer
-
Shandong Cancer Hospital and InstituteNot yet recruiting
-
Nancy Lin, MDGenentech, Inc.Active, not recruitingHER2-positive Metastatic Breast Cancer | Central Nervous System MetastasesUnited States
-
Peking University People's HospitalRecruitingHER2-positive Early Breast CancerChina